VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $202,092 | -61.8% | 21,568 | +0.1% | 0.00% | -50.0% |
| Q2 2023 | $528,745 | +14.4% | 21,555 | +8.5% | 0.00% | +100.0% |
| Q1 2023 | $462,189 | -23.0% | 19,862 | -16.2% | 0.00% | -50.0% |
| Q4 2022 | $599,923 | +39.2% | 23,703 | +5.7% | 0.00% | 0.0% |
| Q3 2022 | $431,000 | -22.5% | 22,415 | +2.8% | 0.00% | 0.0% |
| Q2 2022 | $556,000 | -18.8% | 21,796 | -18.2% | 0.00% | +100.0% |
| Q1 2022 | $685,000 | -51.0% | 26,639 | -20.2% | 0.00% | -66.7% |
| Q4 2021 | $1,399,000 | -13.9% | 33,398 | -10.6% | 0.00% | -40.0% |
| Q3 2021 | $1,625,000 | -16.9% | 37,339 | -9.7% | 0.01% | -16.7% |
| Q2 2021 | $1,955,000 | +14.7% | 41,357 | +24.5% | 0.01% | +20.0% |
| Q1 2021 | $1,704,000 | +94.5% | 33,231 | +1.6% | 0.01% | +66.7% |
| Q4 2020 | $876,000 | +231.8% | 32,695 | +325.4% | 0.00% | +200.0% |
| Q3 2020 | $264,000 | +0.4% | 7,685 | +19.6% | 0.00% | 0.0% |
| Q2 2020 | $263,000 | – | 6,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |